|
This groundbreaking
study analyzes how leading pharmaceutical companies are strategically
leveraging the medical liaison function. As a subscriber to this
study, you will learn how to best maximize the use of this type of
personnel. For each target company, the study provides the
following information:
 | Strategic approach
to the medical liaison function |
 | Response to OIG
guidelines |
 | Organizational
structure/reporting relationships by title |
 | Distribution of
personnel by business unit/therapeutic area |
 | Key roles by title
|
 | Typical salary range
by title |
 | Description of
incentive package by title |
 | Evaluation methods |
The study also analyzes
each company's philosophy about the medical liaison function, including:
 | Quantitative and
qualitative methods for valuing the function |
 | Implications
of Office of Inspector General guidelines and recent litigation on the
liaison role |
This one-of-a-kind report captures the
responses of over 100 practicing oncologists in the United States – as
they are asked to rate the effectiveness of leading oncology sales
forces in regard to the following attributes:
 | Product knowledge |
 | Disease-state knowledge |
 | Competitor product knowledge |
 | Sampling frequency |
 | Responsiveness to the needs of the
doctor’s practice |
 | Call frequency |
 | Trustworthiness |
 | And other pertinent areas… |
We not only capture the revealing survey
results, but PharmaForce digs deeper by conducting targeted interviews
with members of the “best” and “worst” performing sales forces to
uncover the reasons for their rankings.
This program analyzes in detail the marketing expenditures of leading
oncology franchises in the top five countries in Europe (i.e., France,
Germany, Italy, Spain and the United Kingdom). The key expenditures
benchmarked include:
 |
Major conventions |
 |
Representative-initiated physician education programs
|
 |
Clinical trials for approved products |
 |
Advocacy/cooperative group grants
|
 |
CME programs |
 |
Journal advertisements |
 |
Printed sales materials |
Analysis of the sales and marketing organizations includes:
 |
Size and structure of the oncology sales force
|
 |
How the oncology product portfolio is managed
|
 |
Organizational structure of oncology sales and
marketing management |
 |
Deployment of other oncology-related field personnel,
such as medical liaisons |
 |
Role of oncology medical liaisons
|
 |
Qualifications and compensation of oncology sales
personnel, including typical salary/bonus ratios
|
* Save 5% -- Mention "PharmCast.com" when
purchase.
To receive more information about the study,
please click on the
following "Request for Info" link.
|